The Science of Scale: Converting Clinical Excellence to Commercial Success

Maryland entrepreneur, CEO, investor, and advisor, Deborah Hemingway, PhD, Managing Partner, Ecphora Capital, welcomes special guest David Goldstein, CEO & AI Innovator, Author, Speaker, and Investor.

SCHEDULE

11:30am - Networking + Lunch

12:00pm - Seminar & Discussion

OVERVIEW

Are you a medtech or life sciences founder looking to take your innovative clinical breakthroughs to market? Join us for an insightful workshop designed to bridge the gap between clinical excellence and commercial success.

Learn the critical steps of transforming groundbreaking clinical research into scalable, market-ready solutions.

You’ll gain practical strategies for navigating regulatory hurdles, securing funding, building your brand, and accelerating product adoption. Through an interactive discussion and real-world case studies, you’ll leave with a clearer roadmap for scaling your company and turning clinical achievements into commercial milestones. This workshop is a must-attend for any founder aiming to turn vision into impact in the competitive medtech and life sciences landscape

Don’t miss this opportunity to connect with peers, learn from industry leaders, and elevate your startup to the next level.

ABOUT DAVID GOLDSTEIN

With nearly two decades as a serial entrepreneur, David Goldstein has built multiple successful ventures that earned recognition as a "Top 5 Technology" at Techweek NYC and "Hottest Healthcare Startup" by TechCocktail. His entrepreneurial journey began early – at age 9, while other kids dreamed about playing professional sports, he was sketching plans to own the team.

David's passion for entrepreneurial success extends beyond his own ventures. Having navigated both triumphs and challenges firsthand, he committed himself to helping other founders avoid painful trialand-error learning curves.

This mission inspired him to co-found Scarlet Startups, one of New Jersey's largest tech entrepreneur communities, mentor founders at Tigerlabs Ventures, and serve as a guest lecturer and mentor to MBA students at Rutgers University and Baruch College.

Building on these experiences, David co-founded The 9% Club, a community for founders that provides the tools, systems, and wisdom to experience remarkable business success. His contributions and insights as a Forbes Business Council member shape the strategies of entrepreneurs and business leaders across industries.

When he's not building companies or mentoring entrepreneurs, David spends time with his wife and children, coaches his kids' sports teams, and enjoys playing with his dog.

ABOUT THE 9% CLUB

The 9% Club isn't just another business book – it's your blueprint to joining the elite ranks of 9 Percenters who build unstoppable businesses.

Why do 91% of businesses fail while only 9% dominate their markets?

The brutal truth is this: Most businesses fail because they rely on heroic effort instead of systematic success. While most founders work themselves to exhaustion trying to grow through pure hustle, the elite 9% have discovered how to build self-running businesses using proven systems that make success automatic and predictable.

With this book, you can:

Master David's proprietary Revenue Operating System that eliminates guesswork and creates predictable, scalable growth

Deploy automation systems that give you back 90% of your time while scaling your impact

Join a movement of founders committed to systematic excellence

ECPHORA CAPITAL

Ecphora Capital is an early-stage medtech venture firm in Baltimore supporting the state’s most promising medical device and biotech companies. Learn more.

BIOBUZZ NETWORKS

A leading life sciences ecosystem builder, BioBuzz has grown a vibrant community of industry professionals and leaders across the Mid-Atlantic that captures the attention of a national audience. Since our inception, we’ve remained community-focused, community-forward, & community-driven. That’s why thousands of industry professionals trust BioBuzz as an authority for industry insights and networking. Learn more.

FULTON BANK

Fulton Bank supports your growth from concept to market. Life sciences and technology sectors are rapidly evolving and their Life Sciences & Technology Group is transforming the way they support your unique needs.

From vaccines to medical devices and from cyber to ag tech, Fulton's expertise enables you to focus on making a difference, not on day-to-day finances. Whatever stage you’re in—startup, early growth, or established company—our dedicated team offers products, services, and resources designed to help you succeed. Learn more.

LAUNCHPORT

The LaunchPort™ is a medtech manufacturing accelerator located in Baltimore’s Port Covington. The combined manufacturing and Medtech acceleration center allows medical device start-ups and emerging technology developers the ability to co-locate at an experienced, regulated medical device manufacturing center.

As part of that residency, they can tap into core services (e.g. financial operating systems, quality system development, supply chain activities, regulatory submission/compliance support, reimbursement and revenue model development), while allowing them to focus capital resources on developing critical core competencies. Learn more.